AMPH icon

Amphastar Pharmaceuticals
AMPH

Overview Fund Trends Analyst Outlook Journalist POV

168 hedge funds and large institutions have $678M invested in Amphastar Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 62 increasing their positions, 48 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

2.81% more ownership

Funds ownership: 58.15% → 60.96% (+2.8%)

Holders
168
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$291K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$8.15M
2
+$5.07M
3
+$4.97M
4
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$4.9M
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$2.48M

Top Sellers

1
-$5.67M
2
-$2.88M
3
-$1.88M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$1.47M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$1.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4.41M
27
$4.36M
28
$3.83M
29
$3.59M
30
$2.98M
31
$2.57M
32
$2.44M
33
$2.38M
34
$2.18M
35
$2.05M
36
$1.98M
37
$1.95M
38
$1.86M
39
$1.82M
40
$1.75M
41
$1.71M
42
$1.7M
43
$1.69M
44
$1.69M
45
$1.67M
46
$1.48M
47
$1.37M
48
$1.31M
49
$1.22M
50
$1.22M
1
2
3 4 5